Conditions: Non-erosive Gastroesophageal Reflux Disease
Keywords: non-erosive gastroesophageal reflux disease NERD proton pump inhibitor rabeprazole
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 288
Healthy volunteers: no

Brief summary:
To investigate the efficacy and safety of a 4-week treatment of 5 mg/day or 10 mg/day of E3810 (Pariet (Rabeprazole Sodium)) in patients with non-erosive gastroesophageal reflux disease in a multicenter, randomized, double-blind, comparative study.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: E3810 intervention 2: E3810 intervention 3: Placebo
Intervention descriptions: intervention 1: E3810 5mg: once daily orally for 4 weeks intervention 2: E3810 10mg: once daily orally for 4 weeks intervention 3: Placebo: once daily orally for 4 weeks

Protocol document: